rs11576866

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365951.3(KIF1B):​c.4055+1638A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 152,122 control chromosomes in the GnomAD database, including 5,123 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5123 hom., cov: 32)

Consequence

KIF1B
NM_001365951.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.848

Publications

5 publications found
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
KIF1B Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2A1
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuroblastoma, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365951.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
NM_001365951.3
MANE Select
c.4055+1638A>G
intron
N/ANP_001352880.1
KIF1B
NM_001365952.1
c.4055+1638A>G
intron
N/ANP_001352881.1
KIF1B
NM_015074.3
c.3917+1638A>G
intron
N/ANP_055889.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
ENST00000676179.1
MANE Select
c.4055+1638A>G
intron
N/AENSP00000502065.1
KIF1B
ENST00000377081.5
TSL:1
c.4055+1638A>G
intron
N/AENSP00000366284.1
KIF1B
ENST00000377086.5
TSL:1
c.4055+1638A>G
intron
N/AENSP00000366290.1

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36569
AN:
152004
Hom.:
5111
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0931
Gnomad AMI
AF:
0.432
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.267
Gnomad EAS
AF:
0.284
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.295
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.298
Gnomad OTH
AF:
0.255
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.241
AC:
36600
AN:
152122
Hom.:
5123
Cov.:
32
AF XY:
0.242
AC XY:
17981
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0931
AC:
3865
AN:
41516
American (AMR)
AF:
0.313
AC:
4781
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
926
AN:
3468
East Asian (EAS)
AF:
0.284
AC:
1471
AN:
5186
South Asian (SAS)
AF:
0.250
AC:
1203
AN:
4814
European-Finnish (FIN)
AF:
0.295
AC:
3112
AN:
10550
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.298
AC:
20241
AN:
67996
Other (OTH)
AF:
0.259
AC:
547
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1383
2765
4148
5530
6913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
737
Bravo
AF:
0.238
Asia WGS
AF:
0.273
AC:
946
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.12
DANN
Benign
0.40
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11576866; hg19: chr1-10414432; API